EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Variability of the pharmacokinetic parameters of amikacin in geriatric patients in an intensive care unit



Variability of the pharmacokinetic parameters of amikacin in geriatric patients in an intensive care unit



Ciencia Pharmaceutica 2(4): 287-291



The infections caused by gram-negative germs are an important cause of morbidity and mortality in severely ill patients admitted in an intensive care unit, specially in geriatric patients. In the present work, the inter and intra-individual variability of the amikacin pharmacokinetic parameters are studied in a population of severely ill elderly patients, being compared with the obtained ones in a control group of non-elderly adults patients. The results pointed out a greater variability, both inter and intra-individual, of the amikacin plasma clearance (Clp) in the geriatric age. The intra-individual variability of the apparent volume of distribution is also greater in the geriatric patients than in the adults patients, showing the former a lesser interindividual variability. The results related with the inter-individual variability of the amikacin pharmacokinetic parameters in the population of nongeriatric patients are similar with the reported and recommended in the literature for its use in the bayesian method for parameters estimation. Oppositely, the group of elderly patients showed a clearly greater coefficient of variation of the amikacin Clp than routinely used in pharmacokinetics.

(PDF emailed within 1 workday: $29.90)

Accession: 009715546

Download citation: RISBibTeXText



Related references

Amikacin plasma levels and pharmacokinetic parameters in a geriatric population of intensive care unit patients. Geriatrika (Madrid) 7(4): 56-58, 60-61, 1991

Inter and intra individual variability of amikacin pharmacokinetic parameters in intensive care unit patients. Journal de Pharmacie Clinique 6(1): 109-116, 1987

Population pharmacokinetic parameters for bayesian monitoring of amikacin therapy in intensive care unit patients. European Journal of Clinical Pharmacology 43(4): 435-436, 1992

Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study. Critical Care 19(): 33-33, 2016

Evaluating amikacin dosage regimens in intensive care unit patients: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation. International Journal of Antimicrobial Agents 42(2): 155-160, 2014

Pharmacokinetic parameters and clinical evaluation of piperacillin and pefloxacin in patients from an intensive care unit. European Journal of Pharmacology 183(6): 2373-2374, 1990

Do Intensive Care Unit treatment modalities predict mortality in geriatric patients: An observational study from an Indian Intensive Care Unit. Indian Journal of Critical Care Medicine 18(12): 789-795, 2014

Pharmacokinetics of amikacin in intensive care unit patients. Journal of Clinical Pharmacy and Therapeutics 21(6): 417-421, 1996

Exploration of optimal teicoplanin dosage based on pharmacokinetic parameters for the treatment of intensive care unit patients infected with methicillin-resistant Staphylococcus aureus. Journal of Infection and ChemoTherapy 18(1): 10-16, 2012

Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients. Clinical Pharmacokinetics, 2017

Pharmacokinetics and dosage regimens of amikacin in intensive care unit patients. International Journal of Bio-Medical Computing 36(1-2): 135-137, 1994

Determination of plasma concentrations of amikacin in patients of an intensive care unit. Journal of ChemoTherapy 7(1): 45-49, 1995

Synergistic impact of low serum albumin on intensive care unit admission and high blood urea nitrogen during intensive care unit stay on post-intensive care unit mortality in critically ill elderly patients requiring mechanical ventilation. Geriatrics & Gerontology International 13(1): 107-115, 2013

Pharmacokinetics of once-daily dosing regimen of amikacin in intensive care unit patients. Journal de Pharmacie Clinique 14(1): 49-52, 1995

Variability of vancomycin pharmacokinetic parameters in geriatric patients with normal renal function. Pharmacotherapy 11(3): 286, 1991